Global testing and laboratory services firm Eurofins, said two of its clinical diagnostic testing laboratories in the U.S. now offer testing for evaluation of COVID-19. On March 13, 2020, Viracor Eurofins, one of the largest infectious diseases testing laboratories in the U.S., is launching a stand-alone real time reverse transcriptase PCR assay for the qualitative detection of SARS-CoV-2.